LMNA-linked lipodystrophies: from altered fat distribution to cellular alterations
- 21 November 2011
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 39 (6), 1752-1757
- https://doi.org/10.1042/bst20110675
Abstract
Mutations in the LMNA gene, encoding the nuclear intermediate filaments the A-type lamins, result in a wide variety of diseases known as laminopathies. Some of them, such as familial partial lipodystrophy of Dunnigan and metabolic laminopathies, are characterized by lipodystrophic syndromes with altered fat distribution and severe metabolic alterations with insulin resistance and dyslipidaemia. Metabolic disturbances could be due either to the inability of adipose tissue to adequately store triacylglycerols or to other cellular alterations linked to A-type lamin mutations. Indeed, abnormal prelamin A accumulation and farnesylation, which are clearly involved in laminopathic premature aging syndromes, could play important roles in lipodystrophies. In addition, gene expression alterations, and signalling abnormalities affecting SREBP1 (sterol-regulatory-element-binding protein 1) and MAPK (mitogen-activated protein kinase) pathways, could participate in the pathophysiological mechanisms leading to LMNA (lamin A/C)-linked metabolic alterations and lipodystrophies. In the present review, we describe the clinical phenotype of LMNA-linked lipodystrophies and discuss the current physiological and biochemical hypotheses regarding the pathophysiology of these diseases.Keywords
This publication has 51 references indexed in Scilit:
- LMNA Mutations Induce a Non-Inflammatory Fibrosis and a Brown Fat-Like Dystrophy of Enlarged Cervical Adipose TissueThe American Journal of Pathology, 2011
- Lamin-binding ProteinsCold Spring Harbor Perspectives in Biology, 2010
- Role of A-type lamins in signaling, transcription, and chromatin organizationThe Journal of cell biology, 2009
- Atypical Progeroid Syndrome due to Heterozygous Missense LMNA MutationsJournal of Clinical Endocrinology & Metabolism, 2009
- The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutationJournal of Lipid Research, 2009
- Phenotype and Course of Hutchinson–Gilford Progeria SyndromeThe New England Journal of Medicine, 2008
- HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cellsProceedings of the National Academy of Sciences of the United States of America, 2007
- “Laminopathies”: A wide spectrum of human diseasesExperimental Cell Research, 2007
- Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophyJCI Insight, 2007
- Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophyMetabolism, 2007